| 标题 |
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of oncology : official journal of the European Society for Medical Oncology 作者:Choueiri TK; Albigès L; McDermott DF; Hammers HJ; Escudier B; et al 出版日期:2026/07/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)